Anatomical connectivity mapping shows sensitivity to treatment in Alzheimers disease
02 Dec 2013
A paper published in the journal Human Brain Mapping has shown that Bioxydyn's anatomical connectivity mapping (ACM) technique demonstrates sensitivity to conventional treatment in Alzheimer's disease. The paper by Bozzali et al, 'Brain Tissue Modifications Induced by Cholinergic Therapy in Alzheimer’s Disease' represents a major step forward for the use of ACM as it is the first application of the technique in a treatment setting. Previous work by the same group has shown sensitivity to the early degenerative effects associated with Alheimer's disease and that ACM reflects changes in cognitive funciton in multiple sclerosis.